A New Way to Assess Cardiovascular Disease Risk

<p><span style="font-weight: 400;">Early detection of cardiovascular disease can be life-changing. Various methods are used to assess risk. Problem is, many identify cardiac disease only after it has progressed to later stages. High-sensitivity troponin screening uses a blood sample to detect elevated risk of cardiovascular disease, years before most other methods. In fact, hs-Troponin is so sensitive that it may allow clinicians to forecast heart attacks a decade before they happen. In this conversation between our Wellness host, Dr. Peter Nord, Medcan’s chief medical officer, and</span> <span style= "font-weight: 400;">Tricia Ravalico,</span> <span style= "font-weight: 400;">Director, Global Scientific Leadership and Education at Abbott, we explore the development of the</span> <span style="font-weight: 400;">hs-Troponin test and describe why it is so innovative.</span></p> <p><span style="font-weight: 400;">Check out the <a href= "https://www.eatmovethinkpodcast.com/podcast/ep145-assessing-cardiovascular-risk" target="_blank" rel="noopener">episode webpage</a> for links and more info.</span></p> <p> </p> <p> </p>